Robert William Kerwin

BMJ 2007; 334 doi: (Published 31 May 2007) Cite this as: BMJ 2007;334:1170
  1. Anthony David

    Leading psychopharmacologist in schizophrenia

    When Rob Kerwin arrived at the Maudsley to begin his psychiatric training his bosses were secretly in awe of him. For he was in the vanguard of a new breed of psychiatrists—thoroughly trained in neuroscience, experienced in research, eager to shape the field in their image. Their attitude was appropriate: within three years Rob was a full time member of the academic staff and publishing research supporting a crucial role of glutamate in schizophrenia.

    Rob had comparatively humble beginnings in Salford but won a place at Trinity College, Cambridge, to study medicine. After completing preclinical studies he obtained a Medical Research Council PhD studentship in pharmacology at Bristol University, where he studied dopamine and other neurotransmitters in animal models. He also did some postdoctoral work with the late David Marsden at the Institute of Neurology. He completed his clinical training at Westminster Medical School and embarked on further clinical and research work in cardiology at the …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription